Skip to main content

Safeway ex-CEO says company did 'at least 100 hours' of due diligence on Theranos before signing deal

By CNBC
| October 13, 2021

SAN JOSE, CALIF. — Former Safeway CEO Steve Burd said on Tuesday that his company knew it was taking a risk by partnering with blood-testing start-up Theranos, and he acknowledged that a deal would have been good for the grocery chain's stock price.

Tagged Under:

View the discussion thread.

Most Popular

#1

The signs patients have the delta variant are different than original COVID-19

Cough, fever, and shortness of breath are common COVID-19 symptoms. Sinus congestion, runny nose and sore throat are symptoms of becoming infected with the delta variant. Sneezing more than usual...

#2

'COVID arm' rash seen after Moderna vaccine annoying but harmless, doctors say

An angry red rash being called “COVID arm” is a harmless but annoying response in some people who get the Moderna vaccine. Aside from sometimes being itchy, it doesn't appear to be dangerous, and...

#3

2022 Medicare Advantage Plan Overview, Part One: Costs and Leading Carriers

"Medicare consumers overall ... crave stability of benefits and a hassle-free experience that gets them the care and coverage they need at a price they can afford," says one health plan executive. ...

#4

The Huge Opportunity to Use Technology to Bring 'Great Healthcare to More People': Interview With Clover Health's Andrew Toy

The visionary executive of a technology-oriented Medicare Advantage company outlines the future in this sector and the importance of being a leader of Asian descent in healthcare. ...

#5

What we know about AY.4.2, a delta subvariant that's spiking cases in the U.K.

The delta variant is still the overwhelmingly dominant coronavirus strain in California and the U.S., but one of its descendants is starting to gain traction overseas. Known as AY.4.2, it's on the...